Rubin Jonathan has filed 60 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1250 shares of SUPERNUS PHARMACEUTICALS, INC. ($SUPN) on February 25, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 1250 | $0.00 | 14,016.0000 | 56,552,741 | 9.79% | 0.00% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 675 | $50.69 | 13,341.0000 | 56,552,741 | 4.82% | 0.00% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 1250 | $0.00 | 1,250.0000 | 56,552,741 | 50.00% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 750 | $0.00 | 12,556.0000 | 56,552,741 | 6.35% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 603 | $51.35 | 11,806.0000 | 56,552,741 | 4.86% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 1125 | $0.00 | 12,409.0000 | 56,552,741 | 9.97% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 1250 | $0.00 | 2,500.0000 | 56,552,741 | 33.33% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 750 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 1125 | $0.00 | 3,375.0000 | 56,552,741 | 25.00% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 671 | $0.00 | 12,766.0000 | 56,552,741 | 4.99% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 1250 | $0.00 | 13,437.0000 | 56,552,741 | 10.26% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 369 | $50.86 | 12,187.0000 | 56,552,741 | 2.94% | 0.00% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 13500 | $0.00 | 13,500.0000 | 56,552,741 | 9999.99% | 0.02% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Restricted Stock Unit | 3000 | $0.00 | 3,000.0000 | 56,552,741 | 9999.99% | 0.01% |
| Sept. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Common Stock | 1875 | $0.00 | 11,855.0000 | 55,958,537 | 18.79% | 0.00% |
| Sept. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Performance Share Unit | 1875 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| Sept. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 840 | $46.21 | 11,015.0000 | 55,958,537 | 7.09% | 0.00% |
| Sept. 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Performance Share Unit | 1875 | $0.00 | 1,875.0000 | 55,958,537 | 9999.99% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 577 | $33.05 | 9,635.0000 | 55,958,537 | 5.65% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 314 | $33.05 | 10,789.0000 | 55,958,537 | 2.83% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 577 | $33.05 | 10,212.0000 | 55,958,537 | 5.35% | 0.00% |
| Feb. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 1250 | $0.00 | 11,103.0000 | 55,958,537 | 12.69% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Common Stock | 1875 | $0.00 | 8,780.0000 | 55,958,537 | 27.15% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | S | Common Stock | 927 | $39.15 | 7,853.0000 | 55,958,537 | 10.56% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 750 | $0.00 | 8,603.0000 | 55,958,537 | 9.55% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 1250 | $0.00 | 9,853.0000 | 55,958,537 | 14.53% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Performance Share Units | 1875 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 750 | $0.00 | 750.0000 | 55,958,537 | 50.00% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 1250 | $0.00 | 3,750.0000 | 55,958,537 | 25.00% | 0.00% |
| Feb. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 1250 | $0.00 | 2,500.0000 | 55,958,537 | 33.33% | 0.00% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 55,958,537 | 9999.99% | 0.04% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 55,958,537 | 9999.99% | 0.01% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Performance Share Units | 1875 | $0.00 | 1,875.0000 | 55,958,537 | 9999.99% | 0.00% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Performance Share Unit | 1875 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.00% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Common Stock | 750 | $0.00 | 5,822.0000 | 56,016,350 | 14.79% | 0.00% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 281 | $35.59 | 5,541.0000 | 56,016,350 | 4.83% | 0.00% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Common Stock | 1875 | $0.00 | 7,416.0000 | 56,016,350 | 33.84% | 0.00% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 821 | $35.59 | 6,595.0000 | 56,016,350 | 11.07% | 0.00% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Performance Share Unit | 750 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.00% |
| Dec. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Performance Share Unit | 1875 | $0.00 | 1,875.0000 | 56,016,350 | 9999.99% | 0.00% |
| Dec. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Performance Share Unit | 750 | $0.00 | 750.0000 | 56,016,350 | 9999.99% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 1250 | $0.00 | 5,208.0000 | 55,506,828 | 31.58% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 567 | $29.06 | 4,641.0000 | 55,506,828 | 10.89% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 1250 | $0.00 | 3,750.0000 | 55,506,828 | 25.00% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 55,506,828 | 9999.99% | 0.05% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Restricted Stock Unit | 5000 | $0.00 | 5,000.0000 | 55,506,828 | 9999.99% | 0.01% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Unit | 750 | $0.00 | 1,500.0000 | 55,506,828 | 33.33% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | F | Common Stock | 303 | $27.94 | 3,958.0000 | 55,506,828 | 7.11% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 750 | $0.00 | 4,261.0000 | 55,506,828 | 21.36% | 0.00% |
| Dec. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | Sr. VP, Chief Medical Officer | M | Common Stock | 600 | $0.00 | 3,447.0000 | 61,679,800 | 21.07% | 0.00% |
| Dec. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | Sr. VP, Chief Medical Officer | F | Common Stock | 204 | $27.66 | 3,243.0000 | 61,679,800 | 5.92% | 0.00% |
| Dec. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | Sr. VP, Chief Medical Officer | M | Performance Share Unit | 600 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| Dec. 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Performance Share Unit | 600 | $0.00 | 600.0000 | 61,679,800 | 9999.99% | 0.00% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Restricted Stock Units | 5000 | $0.00 | 5,000.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 61,679,800 | 9999.99% | 0.03% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | A | Common Stock | 750 | $0.00 | 2,497.0000 | 61,679,800 | 42.93% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | D | Restricted Stock Units | 750 | $0.00 | 2,250.0000 | 61,679,800 | 25.00% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Performance Share Unit | 1500 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | SVP, Chief Medical Officer | M | Common Stock | 1500 | $0.00 | 1,500.0000 | 61,679,800 | 9999.99% | 0.00% |
| Jan. 12, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Rubin Jonathan | Sr. VP, Chief Medical Officer | A | Performance Share Unit | 1500 | $0.00 | 1,500.0000 | 61,679,800 | 9999.99% | 0.00% |